HSV, axonal transport and Alzheimers disease: In vitro and in vivo evidence for causal relationships

Future Virology

Volumn 7, Issue 9, 2012, Pages 885-899

  Bearer, Elaine L ^a  

^a UNIVERSITY OF NEW MEXICO HEALTH SCIENCES CENTER   (United States)

Author keywords

A; Alzheimers disease; amyloid precursor protein; APP; cerebrospinal fluid; CNS; encephalitis; fast axonal transport; HSV; senile plaques; trigeminal ganglion; trigeminal nucleus

Indexed keywords

VIRUS DNA;

ALZHEIMER DISEASE; AUTOPSY; CORRELATION ANALYSIS; HERPES SIMPLEX VIRUS; HOST; IN VITRO STUDY; IN VIVO STUDY; NERVE ENDING; PERIKARYON; PRIORITY JOURNAL; RETROGRADE NERVE FIBER TRANSPORT; REVIEW; SENSORY NERVE; TRIGEMINUS GANGLION; VIRUS LATENCY; VIRUS REPLICATION;

SIMPLEXVIRUS;

EID: 84866708095     PISSN: 17460794     EISSN: 17460808     Source Type: Journal    
DOI: 10.2217/fvl.12.81     Document Type: Review

References (111)

1. Roizman B, Knipe D. Herpes simplex viruses and their replication. In: Fields Virology. Knipe D, Howley P (Eds). Lippincott Williams & Wilkins, PA, USA 2399-2461 (2001).
2. Su YH, Moxley MJ, Ng AK et al. Stability and circularization of herpes simplex virus type 1 genomes in quiescently infected PC12 cultures. J. Gen. Virol. 83(Pt 12), 2943-2950 (2002).
3. Mellerick DM, Fraser NW. Physical state of the latent herpes simplex virus genome in a mouse model system: evidence suggesting an episomal state. Virology 158(2), 265-275 (1987).
4. Farooq AV, Shukla D. Corneal latency and transmission of herpes simplex virus-1. Future Virol. 6(1), 101-108 (2011).
5. Bearer EL. Perspectives on herpes-APP interactions. Aging Cell 3(2), 81-84 (2004).
6. Itzhaki RF, Dobson CB, Wozniak MA. Commentary on 'Fast anterograde transport of herpes simplex virus: role for the amyloid precursor protein of Alzheimer's disease' by Prasanna Satpute-Krishnan et al. Aging Cell 2(6), 305-318 (2003). Aging Cell 3(2), 79-80 (2004).
7. Cheng SB, Ferland P, Webster P, Bearer EL. Herpes simplex virus dances with amyloid precursor protein while exiting the cell. PLoS One 6(3), e17966 (2011).
8. Xu F, Lee FK, Morrow RA et al. Seroprevalence of herpes simplex virus type 1 in children in the United States. J. Pediatr. 151(4), 374-377 (2007).
9. Xu F, Sternberg MR, Kottiri BJ et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA 296(8), 964-973 (2006).
10. Peter JB, Sevall JS. Review of 3200 serially received CSF samples submitted for type-specific HSV detection by PCR in the reference laboratory setting. Mol. Cell. Probes 15(3), 177-182 (2001).
11. Ball MJ, Mathews R, Steiner I et al. Latent HSV 1 virus in trigeminal ganglia: the optimal site for linking prevention of Alzheimer's disease to vaccination. Neurobiol. Aging 22(5), 705-709; discussion 717-719 (2001).
12. Pevenstein SR, Williams RK, McChesney D, Mont EK, Smialek JE, Straus SE. Quantitation of latent varicella-zoster virus and herpes simplex virus genomes in human trigeminal ganglia. J. Virol. 73(12), 10514-10518 (1999).
13. Hill JM, Ball MJ, Neumann DM et al. The high prevalence of herpes simplex virus type 1 DNA in human trigeminal ganglia is not a function of age or gender. J. Virol. 82(16), 8230-8234 (2008).
14. Jamieson GA, Maitland NJ, Wilcock GK, Yates CM, Itzhaki RF. Herpes simplex virus type 1 DNA is present in specific regions of brain from aged people with and without senile dementia of the Alzheimer type. J. Pathol. 167(4), 365-368 (1992).
15. Hemling N, Roytta M, Rinne J et al. Herpesviruses in brains in Alzheimer's and Parkinson's diseases. Ann. Neurol. 54(2), 267-271 (2003).
16. Mori I, Kimura Y, Naiki H et al. Reactivation of HSV-1 in the brain of patients with familial Alzheimer's disease. J. Med. Virol. 73(4), 605-611 (2004).
17. Jamieson GA, Maitland NJ, Wilcock GK, Craske J, Itzhaki RF. Latent herpes simplex virus type 1 in normal and Alzheimer's disease brains. J. Med. Virol. 33(4), 224-227 (1991).
18. Bertrand P, Guillaume D, Hellauer K et al. Distribution of herpes simplex virus type 1 DNA in selected areas of normal and Alzheimer's disease brains: a PCR study. Neurodegeneration 2, 201-208 (1993).
19. Lin WR, Wozniak MA, Wilcock GK, Itzhaki RF. Cytomegalovirus is present in a very high proportion of brains from vascular dementia patients. Neurobiol. Dis. 9(1), 82-87 (2002).
20. Wozniak MA, Mee AP, Itzhaki RF. Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques. J. Pathol. 217(1), 131-138 (2009).
21. Sanders VJ, Felisan SL, Waddell AE et al. Presence of herpes simplex DNA in surgical tissue from human epileptic seizure foci detected by polymerase chain reaction: preliminary study. Arch. Neurol. 54(8), 954-960 (1997).
22. Sanders VJ, Felisan S, Waddell A, Tourtellotte WW. Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction. J. Neurovirol. 2(4), 249-258 (1996).
23. Itzhaki RF, Lin WR, Shang D, Wilcock GK, Faragher B, Jamieson GA. Herpes simplex virus type 1 in brain and risk of Alzheimer's disease. Lancet 349(9047), 241-244 (1997).
24. Svensson A, Tunback P, Nordstrom I, Padyukov L, Eriksson K. Polymorphisms in TLR3 confers natural resistance to HSV-2 infection. J. Gen. Virol. 93(Pt 8), 1717-1724 (2012).
25. Moraru M, Cisneros E, Gomez-Lozano N et al. Host genetic factors in susceptibility to herpes simplex type 1 virus infection: contribution of polymorphic genes at the interface of innate and adaptive immunity. J. Immunol. 188(9), 4412-4420 (2012).
26. Demontis D, Nyegaard M, Buttenschon HN et al. Association of GRIN1 and GRIN2A-D with schizophrenia and genetic interaction with maternal herpes simplex virus-2 infection affecting disease risk. Am. J. Med. Genet. B Neuropsychiatr. Genet. 156B(8), 913-922 (2011).
27. Chatterjee K, Dandara C, Gyllensten U et al. A Fas gene polymorphism influences herpes simplex virus type 2 infection in South African women. J. Med. Virol. 82(12), 2082-2086 (2010).
28. Kriesel JD, Jones BB, Matsunami N et al. C21orf91 genotypes correlate with herpes simplex labialis (cold sore) frequency: description of a cold sore susceptibility gene. J. Infect. Dis. 204(11), 1654-1662 (2011).
29. Beffert U, Bertrand P, Champagne D, Gauthier S, Poirier J. HSV-1 in brain and risk of Alzheimer's disease. Lancet 351(9112), 1330-1331 (1998).
30. Guzman-Sanchez F, Valdivieso F, Burgos JS. Aging-related neurostructural, neuropathological, and behavioral changes associated with herpes simplex virus type 1 brain infection in mice. J. Alzheimers Dis. 30(4), 779-790 (2012).
31. Lin W-R, Wozniak MA, Esiri MM, Klenerman P, Itzhaki RF. Herpes simplex encephalitis: involvement of apolipoprotein E. J. Neurol. Neurosurg. Psychiatry 70, 117-119 (2001).
32. Eshleman E, Shahzad A, Cohrs RJ. Varicella zoster virus latency. Future Virol. 6(3), 341-355 (2011).
33. Gilden DH, Kleinschmidt-Demasters BK, Laguardia JJ, Mahalingam R, Cohrs RJ. Neurologic complications of the reactivation of varicella-zoster virus. N. Engl. J. Med. 342(9), 635-645 (2000).
34. Gilden DH, Mahalingam R, Cohrs RJ, Tyler KL. Herpesvirus infections of the nervous system. Nat. Clin. Pract. Neurol. 3(2), 82-94 (2007).
35. Itzhaki RF, Wozniak MA. Herpes simplex virus type 1, apolipoprotein E, and cholesterol: a dangerous liaison in Alzheimer's disease and other disorders. Prog. Lipid Res. 45(1), 73-90 (2006).
36. Wozniak MA, Shipley SJ, Dobson CB et al. Does apolipoprotein E determine outcome of infection by varicella zoster virus and by Epstein Barr virus? Eur. J. Hum. Genet. 15(6), 672-678 (2007).
37. Opsahl ML, Kennedy PG. Investigating the presence of human herpesvirus 7 and 8 in multiple sclerosis and normal control brain tissue. J. Neurol. Sci. 240(1-2), 37-44 (2006).
38. Honjo K, Van Reekum R, Verhoeff NP. Alzheimer's disease and infection: do infectious agents contribute to progression of Alzheimer's disease? Alzheimers Dement. 5(4), 348-360 (2009).
39. Tavazzi E, White MK, Khalili K. Progressive multifocal leukoencephalopathy: clinical and molecular aspects. Rev. Med. Virol. 22(1), 18-32 (2012).
40. Miklossy J. Alzheimer's disease-a neurospirochetosis. Analysis of the evidence following Koch's and Hill's criteria. J. Neuroinflammation 8, 90 (2011).
41. Miklossy J, Khalili K, Gern L et al. Borrelia burgdorferi persists in the brain in chronic lyme neuroborreliosis and may be associated with Alzheimer disease. J. Alzheimers Dis. 6(6), 639-649; discussion 673-681 (2004).
42. Ushijima Y, Luo C, Goshima F, Yamauchi Y, Kimura H, Nishiyama Y. Determination and analysis of the DNA sequence of highly attenuated herpes simplex virus type 1 mutant HF10, a potential oncolytic virus. Microbes Infect. 9(2), 142-149 (2007).
43. Szpara ML, Parsons L, Enquist LW. Sequence variability in clinical and laboratory isolates of herpes simplex virus 1 reveals new mutations. J. Virol. 84(10), 5303-5313 (2010).
44. McGeoch DJ, Cunningham C, Mcintyre G, Dolan A. Comparative sequence analysis of the long repeat regions and adjoining parts of the long unique regions in the genomes of herpes simplex viruses types 1 and 2. J. Gen. Virol. 72 (Pt 12), 3057-3075 (1991).
45. Mcgeoch DJ, Dolan A, Donald S, Brauer DH. Complete DNA sequence of the short repeat region in the genome of herpes simplex virus type 1. Nucleic Acids Res. 14(4), 1727-1745 (1986).
46. Aurelius E. Herpes simplex encephalitis. Early diagnosis and immune activation in the acute stage and during long-term follow-up. Scand. J. Infect. Dis. Suppl. 89, 3-62 (1993).
47. Kaufman HE, Azcuy AM, Varnell ED, Sloop GD, Thompson HW, Hill JM. HSV-1 DNA in tears and saliva of normal adults. Invest. Ophthalmol. Vis. Sci. 46(1), 241-247 (2005).
48. Cohrs RJ, Mehta SK, Schmid DS, Gilden DH, Pierson DL. Asymptomatic reactivation and shed of infectious varicella zoster virus in astronauts. J. Med. Virol. 80(6), 1116-1122 (2008).
49. Nagel MA, Choe A, Cohrs RJ et al. Persistence of varicella zoster virus DNA in saliva after herpes zoster. J. Infect. Dis. 204(6), 820-824 (2011).
50. Elion GB, Furman PA, Fyfe JA, De Miranda P, Beauchamp L, Schaeffer HJ. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc. Natl Acad. Sci. USA 74(12), 5716-5720 (1977).
51. Fyfe JA, Keller PM, Furman PA, Miller RL, Elion GB. Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine. J. Biol. Chem. 253(24), 8721-8727 (1978).
52. Schaeffer HJ, Beauchamp L, De Miranda P, Elion GB, Bauer DJ, Collins P. 9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group. Nature 272(5654), 583-585 (1978).
53. Elion GB. Acyclovir: discovery, mechanism of action, and selectivity. J. Med. Virol. (Suppl. 1), 2-6 (1993).
54. De Clercq E, Krajewska E, Descamps J, Torrence PF. Anti-herpes activity of deoxythymidine analogues: specific dependence on virus-induced deoxythymidine kinase. Mol. Pharmacol. 13(5), 980-984 (1977).
55. Whitley RJ. The use of antiviral drugs during the neonatal period. Clin. Perinatol. 39(1), 69-81 (2012).
56. Lin WR, Wozniak MA, Cooper RJ, Wilcock GK, Itzhaki RF. Herpesviruses in brain and Alzheimer's disease. J. Pathol. 197(3), 395-402 (2002).
57. Brown WD, Bearer EL, Donahue JE. Chronic active herpes simplex type 2 encephalitis in an asymptomatic immunocompetent child. J. Child Neurol. 25(7), 901-908 (2010).
58. Kimberlin DW, Whitley RJ, Wan W et al. Oral acyclovir suppression and neurodevelopment after neonatal herpes. N. Engl. J. Med. 365(14), 1284-1292 (2011).
59. Jankowsky JL, Slunt HH, Gonzales V et al. Persistent amyloidosis following suppression of Abeta production in a transgenic model of Alzheimer disease. PLoS Med. 2(12), e355 (2005).
60. Bearer EL, Breakefield XO, Schuback D, Reese TS, Lavail JH. Retrograde axonal transport of herpes simplex virus: evidence for a single mechanism and a role for tegument. Proc. Natl Acad. Sci. USA 97(14), 8146-8150 (2000).
61. Bearer EL, Satpute-Krishnan P. The role of the cytoskeleton in the life cycle of viruses and intracellular bacteria: tracks, motors, and polymerization machines. Curr. Drug Targets Infect. Disord. 2(3), 247-264 (2002).
62. Satpute-Krishnan P, Degiorgis JA, Bearer EL. Fast anterograde transport of herpes simplex virus: role for the amyloid precursor protein of alzheimer's disease. Aging Cell 2(6), 305-318 (2003).
63. Snyder A, Bruun B, Browne HM, Johnson DC. A herpes simplex virus gD-YFP fusion glycoprotein is transported separately from viral capsids in neuronal axons. J. Virol. 81(15), 8337-8340 (2007).
64. Snyder A, Polcicova K, Johnson DC. Herpes simplex virus gE/gI and US9 proteins promote transport of both capsids and virion glycoproteins in neuronal axons. J. Virol. 82(21), 10613-10624 (2008).
65. Snyder A, Wisner TW, Johnson DC. Herpes simplex virus capsids are transported in neuronal axons without an envelope containing the viral glycoproteins. J. Virol. 80(22), 11165-11177 (2006).
66. Antinone SE, Zaichick SV, Smith GA. Resolving the assembly state of herpes simplex virus during axon transport by live-cell imaging. J. Virol. 84(24), 13019-13030 (2010).
67. Negatsch A, Granzow H, Maresch C et al. Ultrastructural analysis of virion formation and intraaxonal transport of herpes simplex virus type 1 in primary rat neurons. J. Virol. 84(24), 13031-13035 (2010).
68. Alconada A, Bauer U, Sodeik B, Hoflack B. Intracellular traff?ic of herpes simplex virus glycoprotein gE: characterization of the sorting signals required for its trans-Golgi network localization. J. Virol. 73, 377-387 (1999).
69. Ibiricu I, Huiskonen JT, Dohner K, Bradke F, Sodeik B, Grunewald K. Cryo electron tomography of herpes simplex virus during axonal transport and secondary envelopment in primary neurons. PLoS Pathog. 7(12), e1002406 (2011).
70. Radtke K, Kieneke D, Wolfstein A et al. Plus-and minus-end directed microtubule motors bind simultaneously to herpes simplex virus capsids using different inner tegument structures. PLoS Pathog. 6(7), e1000991 (2010).
71. Turcotte S, Letellier J, Lippe R. Herpes simplex virus type 1 capsids transit by the trans-Golgi network, where viral glycoproteins accumulate independently of capsid egress. J. Virol. 79(14), 8847-8860 (2005).
72. Cunningham AL, Diefenbach RJ, Miranda-Saksena M et al. The cycle of human herpes simplex virus infection: virus transport and immune control. J. Infect. Dis. 194 Suppl 1, S11-18 (2006).
73. Diefenbach RJ, Miranda-Saksena M, Douglas MW, Cunningham AL. Transport and egress of herpes simplex virus in neurons. Rev. Med. Virol. 18(1), 35-51 (2007).
74. Holland DJ, Miranda-Saksena M, Boadle RA, Armati P, Cunningham AL. Anterograde transport of herpes simplex virus proteins in axons of peripheral human fetal neurons: an immunoelectron microscopy study. J. Virol. 73(10), 8503-8511 (1999).
75. Miranda-Saksena M, Armati P, Boadle RA, Holland DJ, Cunningham AL. Anterograde transport of herpes simplex virus type 1 in cultured, dissociated human and rat dorsal root ganglion neurons. J. Virol. 74(4), 1827-1839 (2000).
76. Penfold ME, Armati P, Cunningham AL. Axonal transport of herpes simplex virions to epidermal cells: evidence for a specialized mode of virus transport and assembly. Proc. Natl Acad. Sci. USA 91(14), 6529-6533 (1994).
77. Kristensson K, Lycke E, Roytta M, Svennerholm B, Vahlne A. Neuritic transport of herpes simplex virus in rat sensory neurons in vitro. Effects of substances interacting with microtubular function and axonal flow [nocodazole, taxol and erythro-9-3-(2-hydroxynonyl)adenine]. J. Gen. Virol. 67 (Pt 9), 2023-2028 (1986).
78. Lycke E, Hamark B, Johansson M, Krotochwil A, Lycke J, Svennerholm B. Herpes simplex virus infection of the human sensory neuron. An electron microscopy study. Arch. Virol. 101(1-2), 87-104 (1988).
79. Lycke E, Kristensson K, Svennerholm B, Vahlne A, Ziegler R. Uptake and transport of herpes simplex virus in neurites of rat dorsal root ganglia cells in culture. J. Gen. Virol. 65 (Pt 1), 55-64 (1984).
80. Lavail JH, Tauscher AN, Sucher A, Harrabi O, Brandimarti R. Viral regulation of the long distance axonal transport of herpes simplex virus nucleocapsid. Neuroscience 146(3), 974-985 (2007).
81. Lee GE, Murray JW, Wolkoff AW, Wilson DW. Reconstitution of herpes simplex virus microtubule-dependent trafficking in vitro. J. Virol. 80(9), 4264-4275 (2006).
82. Satpute-Krishnan P, Degiorgis JA, Conley MP, Jang M, Bearer EL. A peptide zipcode sufficient for anterograde transport within amyloid precursor protein. Proc. Natl Acad. Sci. USA 103(44), 16532-16537 (2006).
83. Mcgraw HM, Awasthi S, Wojcechowskyj JA, Friedman HM. Anterograde spread of herpes simplex virus type 1 requires glycoprotein E and glycoprotein I but not Us9. J. Virol. 83(17), 8315-8326 (2009).
84. O'Regan KJ, Bucks MA, Murphy MA, Wills JW, Courtney RJ. A conserved region of the herpes simplex virus type 1 tegument protein VP22 facilitates interaction with the cytoplasmic tail of glycoprotein E (gE). Virology 358(1), 192-200 (2007).
85. Saldanha CE, Lubinski J, Martin C et al. Herpes simplex virus type 1 glycoprotein E domains involved in virus spread and disease. J. Virol. 74(15), 6712-6719 (2000).
86. Wang F, Tang W, McGraw HM, Bennett J, Enquist LW, Friedman HM. Herpes simplex virus type 1 glycoprotein E is required for axonal localization of capsid, tegument, and membrane glycoproteins. J. Virol. 79(21), 13362-13372 (2005).
87. Wang F, Zumbrun EE, Huang J, Si H, Makaroun L, Friedman HM. Herpes simplex virus type 2 glycoprotein E is required for efficient virus spread from epithelial cells to neurons and for targeting viral proteins from the neuron cell body into axons. Virology 405(2), 269-279 (2010).
88. Dingwell KS, Doering LC, Johnson DC. Glycoproteins E and I facilitate neuron-to-neuron spread of herpes simplex virus. J. Virol. 69(11), 7087-7098 (1995).
89. Farnsworth A, Johnson DC. Herpes simplex virus gE/gI must accumulate in the trans-Golgi network at early times and then redistribute to cell junctions to promote cell-cell spread. J. Virol. 80(7), 3167-3179 (2006).
90. Farnsworth A, Wisner TW, Johnson DC. Cytoplasmic residues of herpes simplex virus glycoprotein gE required for secondary envelopment and binding of tegument proteins VP22 and UL11 to gE and gD. J. Virol. 81(1), 319-331 (2007).
91. Huber MT, Tomazin R, Wisner T, Boname J, Johnson DC. Human cytomegalovirus US7, US8, US9, and US10 are cytoplasmic glycoproteins, not found at cell surfaces, and US9 does not mediate cell-to-cell spread. J. Virol. 76(11), 5748-5758 (2002).
92. Lyman MG, Feierbach B, Curanovic D, Bisher M, Enquist LW. Pseudorabies virus Us9 directs axonal sorting of viral capsids. J. Virol. 81(20), 11363-11371 (2007).
93. Taylor MP, Kramer T, Lyman MG, Kratchmarov R, Enquist LW. Visualization of an alphaherpesvirus membrane protein that is essential for anterograde axonal spread of infection in neurons. MBio 3(2), pii: e00063-12 (2012).
94. De Chiara G, Marcocci ME, Civitelli L et al. APP processing induced by herpes simplex virus type 1 (HSV-1) yields several APP fragments in human and rat neuronal cells. PLoS One 5(11), e13989 (2010).
95. Piacentini R, Civitelli L, Ripoli C et al. HSV-1 promotes Ca2+-mediated APP phosphorylation and Abeta accumulation in rat cortical neurons. Neurobiol. Aging 32(12), 2323.e13-e26 (2011).
96. Santana S, Recuero M, Bullido MJ, Valdivieso F, Aldudo J. Herpes simplex virus type I induces the accumulation of intracellular beta-amyloid in autophagic compartments and the inhibition of the non-amyloidogenic pathway in human neuroblastoma cells. Neurobiol. Aging 33(2), 430 e19-e33 (2012).
97. Wozniak MA, Itzhaki RF, Shipley SJ, Dobson CB. Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation. Neurosci. Lett. 429(2-3), 95-100 (2007).
98. Muresan V, Muresan Z. Is abnormal axonal transport a cause, a contributing factor or a consequence of the neuronal pathology in Alzheimer's disease? Future Neurol. 4(6), 761-773 (2009).
99. Muresan V, Varvel NH, Lamb BT, Muresan Z. The cleavage products of amyloid-beta precursor protein are sorted to distinct carrier vesicles that are independently transported within neurites. J. Neurosci. 29(11), 3565-3578 (2009).
100. Braak H, Thal DR, Ghebremedhin E, Del Tredici K. Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J. Neuropathol. Exp. Neurol. 70(11), 960-969 (2011).
101. Braak H, Thal DR, Matschke J, Ghebremedhin E, Del Tredici K. Age-related appearance of dendritic inclusions in catecholaminergic brainstem neurons. Neurobiol. Aging doi:10.1016/j. neurobiolaging.2012.02.031 (2012) (Epub ahead of print).
102. Carter CJ. Interactions between the products of the Herpes simplex genome and Alzheimer's disease susceptibility genes: relevance to pathological- signalling cascades. Neurochem. Int. 52(6), 920-934 (2008).
103. Wozniak MA, Frost AL, Preston CM, Itzhaki RF. Antivirals reduce the formation of key Alzheimer's disease molecules in cell cultures acutely infected with herpes simplex virus type 1. PLoS One 6(10), e25152 (2011).
104. Feart C, Helmer C, Fleury H et al. Association between IgM anti-herpes simplex virus and plasma amyloid-beta levels. PLoS One 6(12), e29480 (2011).
105. Soscia SJ, Kirby JE, Washicosky KJ et al. The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide. PLoS One 5(3), e9505 (2010).
106. Miklossy J. Emerging roles of pathogens in Alzheimer disease. Expert Rev. Mol. Med. 13, e30 (2011).
107. Panza F, Frisardi V, Imbimbo BP, Seripa D, Solfrizzi V, Pilotto A. Monoclonal antibodies against beta-amyloid (Abeta) for the treatment of Alzheimer's disease: the Abeta target at a crossroads. Expert Opin. Biol. Ther. 11(6), 679-686 (2011).
108. Jonsson T, Atwal JK, Steinberg S et al. A mutation in APP protects against Alzheimer's disease and age-related cognitive decline. Nature 488(7409), 96-99(2012).
109. Hill AB. The environment and disease: association or causation? Proc. R. Soc. Med. 58, 295-300 (1965).
110. Fredericks DN, Relman DA. Sequence-based identification of microbial pathogens: a reconsideration of Koch's postulates. Clin. Microbiol. Rev. 9(1), 18-33 (1996).
111. Letenneur L, Peres K, Fleury H et al. Seropositivity to herpes simplex virus antibodies and risk of Alzheimer's disease: a population-based cohort study. PLoS One 3(11), e3637 (2008).